ESR14 – Moving on to the next adventure

“If you are brave enough to say goodbye, life will reward you with a new hello!” – Paulo Coelho – Our ESR14 Sonia Leonardelli spun the Postdoc Fortune Wheel and took a chance! She hit the jackpot with a new job! Sonia recently has been awarded by the MildredRead More

My secondment in Cambridge

My project involves Next Generation Sequencing (NGS) analysis of melanoma samples to understand resistance mechanisms to immunotherapy. Dr. Adams, who is one of the principal investigators of our Marie-Curie Ph.D. program based at the Wellcome Trust Sanger Institute in Cambridge, offered his help and expertise to perform the bioinformaticRead More

Writing a PhD thesis

By Sathya Muralidhar At the heart of the MELGEN consortium are the PhD students, who have been conducting melanoma research, as part of their PhD. There are many facets to a pursuing a PhD degree, conducting research actually being only one of many. For instance, sharing the findings fromRead More

Immune system: our new fingerprint

In recent years, a considerable number of melanoma patients have shown great tumour regression when treated with immunotherapy agents. However, there is still a long way to go, when it comes to effectively select the patients that will actually benefit from these. My PhD project at Lund University, focusesRead More

Studying genetic changes in melanoma

Have you ever wondered why some melanoma patients do better than others? How is this linked to changes in our genes? In this video, I will highlight part of my research as a PhD student at the Wellcome Sanger Institute in Cambridge, UK.   To learn more, check outRead More

Melanoma: win the battle against your resistance

In the past years, we have drastically improved treatments for melanoma-skin cancer patients. Nevertheless, tumor recurrence still remains an highly lethal matter of our concern.   I’m pursing my PhD project in the melanoma genomics lab-group of Göran Jönssön, where we are specifically working with melanoma cells invulnerable towards current effectiveRead More

Can we slow down skin cancer progression?

The progression from benign cells to melanoma is not fully understood. In addition to genetic alterations, some epigenetic mechanisms, the ones that do not involve DNA sequence, play a role in the development and evolution of melanoma. My PhD project aims to disclose the epigenetic features behind melanoma progression. WeRead More